1. Field
This disclosure relates to implantable weight control devices. More particularly, this disclosure relates to a gastric space filler device which is retrievably implantable in a patient, an improved device and method for delivery of a gastric space filler device, and a method and device for retaining fluid in a gastric space filler device, among other things.
2. General Background
Gastric space fillers used for achieving loss of weight in extremely obese persons have been known in the art. Some gastric space fillers utilized for this purpose function on the principle that an empty bag or space filler is placed into the stomach through the esophagus. Thereafter, the bag or space filler is fully or partially filled with a suitable insufflation fluid, such as saline solution, through a filler tube or catheter which is inserted into the stomach through the mouth or the nose. The space filler occupies space in the stomach thereby leaving less room available for food and creating a feeling of satiety for the obese person. Clinical experience has shown that, for many obese patients, reducing the size of the gastric compartment with gastric space fillers significantly helps to control appetite and accomplish weight loss. The present disclosure is directed to a device which non-operatively reduces the size of the gastric compartment and which is easily removed. Artisans shall readily appreciate that emergency operative morbidity rates and co-morbidity statistics relating to such devices which have migrated beyond the stomach underscore the need for an effective medical device that can be removed.
According to features of the present disclosure, a gastric space filler device and methods effective for reducing stomach volume are disclosed. A gastric space filler comprising at least one inflatable space filler and a sleeve to prevent leakage out of the gastric space filler device is disclosed. The gastric space filler device may be inflated with an insufflation fluid and with mineral oil, which further has the effect of reducing leakage. Delivery systems and methods for inserting a gastric space filler device into a patient are also disclosed. Sheaths and methods for covering a gastric space filler device during delivery into a patient are also disclosed.
According to embodiments of the instant teachings, there is disclosed a gastric space filler device comprising a space filler, an opening to inflate the space filler, and a sleeve that is configured to receive mineral oil between the sleeve and the opening. According to at least one embodiment, the sleeve is disposed between the opening and the outer periphery of the space filler. According to at least one embodiment, the sleeve allows fluid to enter the space filler during inflation, but does not allow fluid to exit the space filler when mineral oil is received between the sleeve and the opening.
According to embodiments of the instant teachings, there is disclosed a gastric space filler device comprising a space filler and a sheath, wherein the sheath at least partially covers the space filler. According to at least one embodiment, the sheath is secured around the space filler with a stitch that can be released by pulling on the stitch. According to at least one embodiment, the sheath automatically uncovers the space filler as the space filler is inflated.
According to embodiments of the instant teachings, there is disclosed a delivery system comprising a delivery lumen, a barb configured for coupling with an infusing lumen of a gastric space filler device, and a docking clip configured for securely attaching the delivery system to the gastric space filler device. According to at least one embodiment, the delivery system contains a handle that, when removed from the infusing lumen, pulls a stitch to release a space filler and simultaneously uncovers a luer for infusing a fluid into the gastric space filler device.
According to embodiments of the instant teachings, there is disclosed a method for treating obesity challenged patients comprising providing a gastric space filler device comprising a space filler, an opening to inflate the space filler with a fluid, and a sleeve disposed between the opening and an outer periphery of the space filler; allowing the fluid to enter the space filler through the opening; and preventing the fluid from exiting the space filler through the opening.
According to embodiments of the instant teachings, there is disclosed a method for emplacing a gastric space filler device in a patient comprising providing a delivery system attached to a gastric space filler device comprising a space filler; covering at least part of the space filler with a sheath; and delivering the delivery system and the gastric space filler device through an esophagus into a stomach of a patient.
The above-mentioned features and objects of the present disclosure will become more apparent with reference to the following description taken in conjunction with the accompanying drawings wherein like reference numerals denote like elements and in which:
According to an embodiment as schematically depicted in
According to an illustrative embodiment, proximal space filler 91A and distal space filler 91B are spaced apart and secured to each other by infusing member 93. According to an illustrative embodiment, the distance between the two space fillers is between at least about 10 to approximately 40 mm. The overall axial length of gastric space filler device 19 is between about 100 and about 300 mm. According to an illustrative embodiment, infusing member 93 may be made of semi-flexible or flexible material. The semi-flexible material may be selected from space filler-compatible polymer, such as, polyethylene, polystyrene, polyurethane, silicone, fluoro-polymer, and co-polymers thereof.
According to an illustrative embodiment, the longitudinal length of proximal space filler 91A is between about 70 and about 80 mm, preferably about 75 mm. Proximal space filler 91A may be expanded to a space volume of between about 100 and about 600 cc. In an embodiment, the longitudinal length of distal space filler 91B is between about 60 and about 70 mm, preferably about 65 mm.
Distal space filler 91B may be expanded to a space volume of between about 100 and about 400 cc. According to a further embodiment, a radial diameter of proximal space filler 91A may be expanded to a diameter between about 40 and about 60 mm, and a radial diameter of distal space filler 91B may be expanded to a diameter between about 20 and about 40 mm. According to an illustrative embodiment, proximal space filler 91A is substantially larger than distal space filler 91B in gastric space filler device 19 to take the advantage of the restricted space at the entrance region of the stomach and to create a better feeling of satiety for the patient. According to an illustrative embodiment, the thickness of proximal space filler 91A and distal space filler 91B is between about 0.2 and about 1.0 mm, effectively between about 0.3 to about 0.5 mm.
According to an embodiment as depicted in
According to an embodiment as depicted in
According to an illustrative embodiment, proximal opening 96A connects proximal space filler 91A to proximal infusing lumen 94A. According to an illustrative embodiment, proximal sleeve 110A wraps around infusing member 93 and covers proximal opening 96A. Proximal sleeve 110A may be disposed between proximal opening 96A and outer periphery of proximal space filler 91A.
As proximal space filler 91A is being inflated, proximal sleeve 110A allows an insufflation fluid to enter proximal space filler 91A from proximal infusing lumen 94A through proximal opening 96A. According to an illustrative embodiment, proximal sleeve 110A allows an insufflation fluid to enter proximal space filler 91A by moving at least part of proximal sleeve 110A away from proximal opening 96A. According to an illustrative embodiment, at least part of proximal sleeve 110A is moved away from proximal opening 96A as a result of higher pressure outside proximal space filler 91A in relation to pressure inside proximal space filler 91A.
According to an illustrative embodiment, after proximal space filler 91A is inflated, proximal sleeve 110A is pressed against proximal opening 96A; thus proximal sleeve 110A does not allow fluid to exit proximal space filler 91A through proximal opening 96A. According to an illustrative embodiment, higher pressure inside proximal space filler 91A, relative to pressure outside proximal space filler 91A, presses proximal sleeve 110A against proximal opening 96A.
According to another embodiment, proximal sleeve 110A is not wrapped around infusing member 93, but is attached to infusing member 93 and is configured to move at least partially away from proximal opening 96A while proximal space filler 91A is being inflated and is also configured to block proximal opening 96A after proximal space filler 91A has been inflated.
According to an embodiment as depicted in
According to an illustrative embodiment, an insufflation fluid, such as a saline solution, is used to inflate proximal space filler 91A or distal space filler 91B to a desired volume effective to fill the desired portion of a stomach of a patient and create the desired feeling of satiety. When proximal space filler 91A is inflated to this point, mineral oil is infused through proximal opening 96A and received between proximal sleeve 110A and proximal opening 96A. The mineral oil displaces the insufflation fluid in the area between proximal sleeve 110A and proximal opening 96A. Mineral oil between proximal sleeve 110A and proximal opening 96A has the effect of decreasing leakage of the insufflation fluid out of proximal space filler 91A through proximal opening 96A. According to an illustrative embodiment, an effective amount of mineral oil is the amount of mineral oil with volume equal to the volume of the insufflation fluid to be displaced by the mineral oil. According to an illustrative embodiment, mineral oil is received between distal sleeve 110B and distal opening 96B. Unexpectedly, this teaching substantially improves leakage and has yet to have been disclosed.
According to an embodiment as depicted in
According to an embodiment as depicted in
According to an illustrative embodiment, delivery system 200 contains proximal barb 206A and distal barb 206B. Proximal barb 206A is in fluid communication with proximal delivery lumen 210A, and distal barb 206B is in fluid communication with distal delivery lumen 210B. When delivery system 200 is securely coupled with proximal end of gastric space filler device 19, proximal barb 206A and distal barb 206B are at least partially inserted into proximal infusing lumen 94A and distal infusing lumen 94B, respectively.
Proximal space filler 91A may be inflated by delivering an insufflation fluid into proximal delivery lumen 210A, thereby delivering insufflation fluid through proximal barb 206A and into proximal infusing lumen 94A. Similarly, distal space filler 91B may be inflated by delivering an insufflation fluid into distal delivery lumen 210B, thereby delivering insufflation fluid through distal barb 206B and into the distal infusing lumen 94B.
According to an embodiment as depicted in
According to an embodiment as depicted in
According to an illustrative embodiment, at least part of stitch 204 is secured by sheath release clip 212 until gastric space filler device 19 is ready to be inserted into patient. Sheath release clip 212, while engaged, secures at least part of stitch 204, such that stitch 204 may not be released. When sheath release clip 212 is removed, stitch 204 is capable of being released.
According to an illustrative embodiment, at least part of stitch 204 is located inside stitch channel 214 of delivery system 200. This allows stitch 204 to be pulled away from gastric space filler device 19 without additional instruments. Where stitch 204 is released from sheath 202 by pulling on an end of stitch 204, stitch 204 may be released by pulling stitch 204 through stitch channel 214.
According to an embodiment as depicted in
According to an embodiment as depicted in
According to an embodiment as depicted in
As distal space filler 91B is inflated, distal sheath 202B is rolled onto itself toward distal end of gastric space filler device 19 and distal portion of central sheath 202C is rolled onto itself toward center of gastric space filler device 19. As proximal space filler 91A is inflated, proximal sheath 202A is rolled onto itself toward proximal end of gastric space filler device 19, and proximal portion of central sheath 202C is rolled onto itself toward center of gastric space filler device 19. In an illustrative embodiment, as proximal space filler 91A is inflated, proximal sheath 202A is rolled onto itself toward delivery system 200 attached to proximal end of gastric space filler device 19, such that when proximal space filler 91A is inflated, proximal sheath 202A is rolled onto delivery system 200 and when delivery system 200 is detached and removed, proximal sheath 202A is removed with delivery system 200.
In an illustrative embodiment, gastric spacer filler device 19 is at least partially covered by two sheaths: proximal sheath 202A and distal sheath 202B. Distal sheath 202B at least partially covers distal space filler 91B until distal space filler 91B is inflated, which causes distal sheath 202B to be rolled onto itself, either toward distal end of gastric space filler device 19 or toward center of gastric space filler device 19. Similarly, proximal sheath 202A at least partially covers proximal space filler 91A until proximal space filler 91A is inflated, which causes proximal sheath 202A to be rolled onto itself, either toward proximal end of gastric space filler device 19 or toward the center of gastric space filler device 19.
In an illustrative embodiment, gastric space filler device 19 is at least partially covered by a single sheath: central sheath 202C. Central sheath 202C at least partially covers each of proximal space filler 91A and distal space filler 91B. As distal space filler 91B is inflated, central sheath 202C is rolled onto itself from proximal end of gastric space filler device 19 toward center of gastric space filler device 19 until central sheath 202C no longer covers distal space filler 91B. As proximal space filler 91A is inflated, central sheath 202C is rolled onto itself from proximal end of gastric space filler device 19 toward center of gastric space filler device 19 until central sheath 202C no longer covers proximal space filler 91A. Alternatively, as proximal space filler 91A is inflated, central sheath 202C may be rolled from center of gastric space filler device 19 toward proximal end of gastric space filler device 19.
While the apparatus and method have been described in terms of what are presently considered to be the most practical embodiments, it is to be understood that the disclosure need not be limited to the disclosed embodiments. It is intended to cover various modifications and similar arrangements included within the spirit and scope of the claims, the scope of which should be accorded the broadest interpretation so as to encompass all such modifications and similar structures. The present disclosure includes any and all embodiments of the following claims.
The present application is a continuation of U.S. patent application Ser. No. 11/768,152, filed Jun. 25, 2007, the disclosure of which is incorporated herein by reference in its entirety. This application incorporates by reference in their entirety each of the following applications: (a) U.S. patent application Ser. No. 11/694,536, filed Mar. 30, 2007; (b) PCT/US06/42336, filed Oct. 31, 2006; (c) PCT/US06/42711, filed Oct. 31, 2006; (d) PCT/US06/42710, filed Oct. 31, 2006; and (e) PCT/US06/48647, filed Dec. 20, 2006.
Number | Name | Date | Kind |
---|---|---|---|
2493326 | Trinder | Jan 1950 | A |
4133315 | Berman et al. | Jan 1979 | A |
4198983 | Becker et al. | Apr 1980 | A |
4246893 | Berson | Jan 1981 | A |
4356824 | Vazquez | Nov 1982 | A |
4368739 | Nelson, Jr. | Jan 1983 | A |
4416267 | Garren et al. | Nov 1983 | A |
4465072 | Taheri | Aug 1984 | A |
4465818 | Shirahata et al. | Aug 1984 | A |
4485805 | Foster, Jr. | Dec 1984 | A |
4543089 | Moss | Sep 1985 | A |
4598699 | Garren et al. | Jul 1986 | A |
4694827 | Weiner et al. | Sep 1987 | A |
4723547 | Kullas et al. | Feb 1988 | A |
4899747 | Garren et al. | Feb 1990 | A |
4940458 | Cohn | Jul 1990 | A |
5073347 | Garren et al. | Dec 1991 | A |
5084061 | Gau et al. | Jan 1992 | A |
5123840 | Nates | Jun 1992 | A |
5234454 | Bangs | Aug 1993 | A |
5259399 | Brown | Nov 1993 | A |
5263934 | Haak | Nov 1993 | A |
5273536 | Savas | Dec 1993 | A |
5318530 | Nelson, Jr. | Jun 1994 | A |
5334187 | Fischell et al. | Aug 1994 | A |
5431173 | Chin et al. | Jul 1995 | A |
5496271 | Burton et al. | Mar 1996 | A |
5516812 | Chu et al. | May 1996 | A |
5575772 | Lennox | Nov 1996 | A |
5639810 | Smith, III et al. | Jun 1997 | A |
5643209 | Fugoso et al. | Jul 1997 | A |
5730722 | Wilk | Mar 1998 | A |
5779728 | Lunsford et al. | Jul 1998 | A |
5857991 | Grothoff et al. | Jan 1999 | A |
5876376 | Schwab et al. | Mar 1999 | A |
5904701 | Daneshvar | May 1999 | A |
5938669 | Klaiber et al. | Aug 1999 | A |
5976073 | Ouchi | Nov 1999 | A |
5993473 | Chan et al. | Nov 1999 | A |
5997503 | Willis et al. | Dec 1999 | A |
6050274 | Gelardi et al. | Apr 2000 | A |
6149621 | Makihara | Nov 2000 | A |
6179878 | Duerig et al. | Jan 2001 | B1 |
6254355 | Gharib | Jul 2001 | B1 |
6276567 | Diaz et al. | Aug 2001 | B1 |
6280411 | Lennox | Aug 2001 | B1 |
6423058 | Edwards et al. | Jul 2002 | B1 |
6427089 | Knowlton | Jul 2002 | B1 |
6454785 | De Hoyos Garza | Sep 2002 | B2 |
6524234 | Ouchi | Feb 2003 | B2 |
6535764 | Imran et al. | Mar 2003 | B2 |
6540789 | Stein et al. | Apr 2003 | B1 |
6547788 | Maguire et al. | Apr 2003 | B1 |
6579301 | Bales et al. | Jun 2003 | B1 |
6592552 | Schmidt | Jul 2003 | B1 |
6613018 | Bagga et al. | Sep 2003 | B2 |
6613037 | Khosravi et al. | Sep 2003 | B2 |
6689051 | Nakada | Feb 2004 | B2 |
6706010 | Miki et al. | Mar 2004 | B1 |
6746460 | Gannoe et al. | Jun 2004 | B2 |
6826428 | Chen et al. | Nov 2004 | B1 |
6850128 | Park | Feb 2005 | B2 |
6866657 | Shchervinsky | Mar 2005 | B2 |
6869431 | Maguire et al. | Mar 2005 | B2 |
6890300 | Lloyd et al. | May 2005 | B2 |
6890346 | Ganz et al. | May 2005 | B2 |
6902535 | Eberhart et al. | Jun 2005 | B2 |
6923754 | Lubock | Aug 2005 | B2 |
6931286 | Sigg et al. | Aug 2005 | B2 |
6939299 | Petersen et al. | Sep 2005 | B1 |
6942680 | Grayzel et al. | Sep 2005 | B2 |
6958052 | Charlton | Oct 2005 | B1 |
7001419 | DiCaprio et al. | Feb 2006 | B2 |
7016735 | Imran et al. | Mar 2006 | B2 |
7020531 | Colliou et al. | Mar 2006 | B1 |
7033373 | de la Torre et al. | Apr 2006 | B2 |
7056305 | Garza Alvarez | Jun 2006 | B2 |
7076305 | Imran et al. | Jul 2006 | B2 |
7081125 | Edwards et al. | Jul 2006 | B2 |
7131945 | Fink et al. | Nov 2006 | B2 |
7483746 | Lee et al. | Jan 2009 | B2 |
7625355 | Yu | Dec 2009 | B2 |
7749254 | Sobelman et al. | Jul 2010 | B2 |
7828749 | Douglas et al. | Nov 2010 | B2 |
7931693 | Binmoeller et al. | Apr 2011 | B2 |
8083757 | Gannoe et al. | Dec 2011 | B2 |
8556925 | Makower et al. | Oct 2013 | B2 |
8840952 | Ashby et al. | Sep 2014 | B2 |
8894568 | Pecor et al. | Nov 2014 | B2 |
9050174 | Pecor et al. | Jun 2015 | B2 |
9149611 | Bouasaysy et al. | Oct 2015 | B2 |
20010022988 | Schwarz et al. | Sep 2001 | A1 |
20010037127 | De Hoyos Garza | Nov 2001 | A1 |
20020055757 | Torre et al. | May 2002 | A1 |
20020107515 | Edwards et al. | Aug 2002 | A1 |
20020161388 | Samuels et al. | Oct 2002 | A1 |
20020173804 | Rousseau | Nov 2002 | A1 |
20030105800 | Cullen | Jun 2003 | A1 |
20030114878 | Diederich et al. | Jun 2003 | A1 |
20030171768 | McGhan | Sep 2003 | A1 |
20030187390 | Bates et al. | Oct 2003 | A1 |
20040044354 | Gannoe et al. | Mar 2004 | A1 |
20040059289 | Garza Alvarez | Mar 2004 | A1 |
20040059290 | Palasis | Mar 2004 | A1 |
20040073162 | Bleam et al. | Apr 2004 | A1 |
20040087902 | Richter | May 2004 | A1 |
20040093058 | Cottone et al. | May 2004 | A1 |
20040106899 | McMichael et al. | Jun 2004 | A1 |
20040116897 | Aboul-Hosn | Jun 2004 | A1 |
20040127915 | Fleenor et al. | Jul 2004 | A1 |
20040186502 | Sampson et al. | Sep 2004 | A1 |
20040220665 | Hossainy et al. | Nov 2004 | A1 |
20040236280 | Rice et al. | Nov 2004 | A1 |
20040236361 | Sakurai | Nov 2004 | A1 |
20040254600 | Zarbatany et al. | Dec 2004 | A1 |
20050027283 | Richard et al. | Feb 2005 | A1 |
20050027313 | Shaker | Feb 2005 | A1 |
20050038415 | Rohr et al. | Feb 2005 | A1 |
20050055039 | Burnett et al. | Mar 2005 | A1 |
20050059990 | Ayala et al. | Mar 2005 | A1 |
20050075624 | Miesel | Apr 2005 | A1 |
20050085792 | Gershowitz | Apr 2005 | A1 |
20050119674 | Gingras | Jun 2005 | A1 |
20050131442 | Yachia et al. | Jun 2005 | A1 |
20050143784 | Imran | Jun 2005 | A1 |
20050159769 | Alverdy | Jul 2005 | A1 |
20050177103 | Hunter et al. | Aug 2005 | A1 |
20050192615 | Torre et al. | Sep 2005 | A1 |
20050267595 | Chen et al. | Dec 2005 | A1 |
20050267596 | Chen et al. | Dec 2005 | A1 |
20050273060 | Levy et al. | Dec 2005 | A1 |
20060058829 | Sampson et al. | Mar 2006 | A1 |
20060178691 | Binmoeller | Aug 2006 | A1 |
20060184112 | Horn et al. | Aug 2006 | A1 |
20060259020 | Sharratt | Nov 2006 | A1 |
20070016262 | Gross et al. | Jan 2007 | A1 |
20070078476 | Hull et al. | Apr 2007 | A1 |
20070083224 | Hively | Apr 2007 | A1 |
20070093728 | Douglas et al. | Apr 2007 | A1 |
20070100367 | Quijano et al. | May 2007 | A1 |
20070100368 | Quijano et al. | May 2007 | A1 |
20070100369 | Cragg et al. | May 2007 | A1 |
20070135829 | Paganon et al. | Jun 2007 | A1 |
20070142770 | Rioux et al. | Jun 2007 | A1 |
20070149994 | Sosnowski et al. | Jun 2007 | A1 |
20070173881 | Birk et al. | Jul 2007 | A1 |
20070233161 | Weller et al. | Oct 2007 | A1 |
20070250020 | Kim et al. | Oct 2007 | A1 |
20070265369 | Muratoglu et al. | Nov 2007 | A1 |
20070265598 | Karasik | Nov 2007 | A1 |
20070288033 | Murature et al. | Dec 2007 | A1 |
20080058887 | Griffin et al. | Mar 2008 | A1 |
20080082056 | Mauch et al. | Apr 2008 | A1 |
20080085887 | Didiuk et al. | Apr 2008 | A1 |
20080097513 | Kaji et al. | Apr 2008 | A1 |
20080119729 | Copa et al. | May 2008 | A1 |
20080172079 | Birk | Jul 2008 | A1 |
20080190363 | Chen et al. | Aug 2008 | A1 |
20080208135 | Annunziata et al. | Aug 2008 | A1 |
20080208241 | Weiner et al. | Aug 2008 | A1 |
20080233167 | Li et al. | Sep 2008 | A1 |
20080243071 | Quijano et al. | Oct 2008 | A1 |
20080243166 | Paganon et al. | Oct 2008 | A1 |
20080255601 | Birk | Oct 2008 | A1 |
20080312679 | Hardert et al. | Dec 2008 | A1 |
20080319471 | Sosnowski et al. | Dec 2008 | A1 |
20090048624 | Alverdy | Feb 2009 | A1 |
20090259236 | Burnett et al. | Oct 2009 | A2 |
20090275973 | Chen et al. | Nov 2009 | A1 |
20090287231 | Brooks et al. | Nov 2009 | A1 |
20100023047 | Simpson | Jan 2010 | A1 |
20100130998 | Alverdy | May 2010 | A1 |
20100234853 | Pecor et al. | Sep 2010 | A1 |
20100243135 | Pepper et al. | Sep 2010 | A1 |
20100251837 | Bouasaysy et al. | Oct 2010 | A1 |
20110172767 | Rathi et al. | Jul 2011 | A1 |
20120191126 | Pecor et al. | Jul 2012 | A1 |
20120271336 | Hamman et al. | Oct 2012 | A1 |
20120271338 | Bouasaysy et al. | Oct 2012 | A1 |
20120289992 | Quijano et al. | Nov 2012 | A1 |
20130035710 | Bouasaysy et al. | Feb 2013 | A1 |
20130053880 | Bouasaysy et al. | Feb 2013 | A1 |
20130102876 | Limon et al. | Apr 2013 | A1 |
20130261654 | Bouasaysy et al. | Oct 2013 | A1 |
20130296914 | Quijano et al. | Nov 2013 | A1 |
20140031850 | Bouasaysy et al. | Jan 2014 | A1 |
20140257358 | Alverdy et al. | Sep 2014 | A1 |
20140371775 | Ashby et al. | Dec 2014 | A1 |
20150216529 | Kwok et al. | Aug 2015 | A1 |
20150238342 | Sosnowski et al. | Aug 2015 | A1 |
20150265811 | Pecor | Sep 2015 | A1 |
Number | Date | Country |
---|---|---|
8708978 | Nov 1987 | DE |
0103481 | Mar 1984 | EP |
0457456 | Nov 1991 | EP |
0485903 | May 1992 | EP |
1781183 | May 2007 | EP |
2862525 | May 2005 | FR |
2892297 | Apr 2007 | FR |
2090747 | Jul 1982 | GB |
2139902 | Nov 1984 | GB |
S57168674 | Oct 1982 | JP |
S6415063 | Jan 1989 | JP |
H091872 | Apr 1989 | JP |
H08322943 | Dec 1996 | JP |
2001128985 | May 2001 | JP |
2006333888 | Dec 2006 | JP |
9000369 | Jan 1990 | WO |
9925418 | May 1999 | WO |
WO-0141700 | Jun 2001 | WO |
WO-0166166 | Sep 2001 | WO |
WO0240081 | May 2002 | WO |
WO-2006035446 | Apr 2006 | WO |
WO-2006056944 | Jun 2006 | WO |
WO-2006128978 | Dec 2006 | WO |
WO-2007027812 | Mar 2007 | WO |
WO-2007053556 | May 2007 | WO |
WO-2007053706 | May 2007 | WO |
WO-2007053707 | May 2007 | WO |
WO-2007075810 | Jul 2007 | WO |
WO-2008042819 | Apr 2008 | WO |
WO-2008121831 | Oct 2008 | WO |
WO-2009112786 | Sep 2009 | WO |
WO-2010048021 | Apr 2010 | WO |
WO-2010115161 | Oct 2010 | WO |
WO-2011011629 | Jan 2011 | WO |
WO-2011011741 | Jan 2011 | WO |
WO-2011011743 | Jan 2011 | WO |
WO-2011024077 | Mar 2011 | WO |
WO-2011038270 | Mar 2011 | WO |
WO-2011097637 | Aug 2011 | WO |
WO-2011127205 | Oct 2011 | WO |
WO-2012048226 | Apr 2012 | WO |
Entry |
---|
International Search Report; International Application No. PCT/US2011/024082, Applicant: ReShape Medical, Inc., Mailing Date Apr. 6, 2011, 10 pages. |
International Search Report; International Application No. PCT/US2011/024077; Applicant: ReShape Medical, Inc., Mailing Date Apr. 6, 2011, 12 pages. |
International Search Report; International Application No. PCT/US2010/042948; Applicant: ReShape Medical, Inc., Mailing Date Apr. 1, 2011, 11 pages. |
International Search Report; International Application No. PCT/US2010/043136; Applicant: ReShape Medical, Inc., Mailing Date Apr. 12, 2011, 9 pages. |
International Search Report; International Application No. PCT/US2010/043134; Applicant: ReShape Medical, Inc., Mailing Date Apr. 27, 2011, 12 pages. |
International Search Report; International Application No. PCT/US2011/0426233; Applicant: ReShape Medical, Inc., Mailing Date Apr. 26, 2011, 9 pages. |
“ReShape Inflatable Gastric Ballon Going on Trial as Weight Loss Option,” MedGadget: Internet Journal of Emerging Medical Technologies. Feb. 4, 2010. (5 pages). |
Wahlen Ch et al. “The BioEnterics Intragastric Balloon: How to use it” Obesity Surgery 2001; 11:524-527. |
Patient Information “Living with the BIB” by INAMED Health (2004). |
International Search Report; International Application No. PCT/US2008/058677, Applicant: ReShape Medical et al., Mailing Date Aug. 21, 2008, 12 pages. |
International Search Report; International Application No. PCT/US2006/042710, Applicant: Abdominus, Inc. et al., Mailing Date Mar. 15, 2007, 9 pages. |
International Search Report; International Application No. PCT/US2006/048647, Applicant: Abdominus, Inc. et al., Mailing Date May 22, 2007, 12 pages. |
International Search Report; International Application No. PCT/US2008/068058, Applicant: ReShape Medical, Inc. et al, Mailing Date Nov. 19, 2008, 11 pages. |
International Search Report; International Application No. PCT/US2006/042711, Applicant: Abdominus, Inc. et al, Mailing Date Mar. 16, 2007, 9 pages. |
Supplementary European Search Report for EP 03726447.0, mailed Mar. 1, 2006. |
International Search Report; International Application No. PCT/US2003/012782, Applicant: Applied Medical Resources Corporation, Mailing Date Oct. 28, 2003, 7 pages. |
International Search Report; International Application No. PCT/US2006/042336, Applicant: Abdominus, Inc., Mailing Date Mar. 14, 2007, 9 pages. |
International Search Report; International Application No. PCT/US2010/029865, Applicant: ReShape Medical, Inc., Mailing Date Jan. 5, 2011, 9 pages. |
Final Office Action; U.S. Appl. No. 11/694,536, Mailing Date Mar. 11, 2011, 13 pages. |
Final Office Action; U.S. Appl. No. 11/768,152, Mailing Date Jan. 19, 2011, 13 pages. |
Extended European Search Report; Application No. EP6827098.3, Applicant: Reshape Medical Corporation, mailed on Aug. 25, 2014, 3 pages. |
Extended European Search Report; Application No. EP6827314.3, Applicant: ReShape Medical Corporation, mailed Aug. 1, 2014, 3 pages. |
Extended European Search Report; Application No. EP6827313.5, Applicant: ReShape Medical Corporation, mailed Jul. 30, 2014, 5 pages. |
Extended European Search Report; Application No. EP6847847.8, Applicant: ReShape Medical Corporation, mailed Aug. 14, 2014, 5 pages. |
Final Office Action: U.S. Appl. No. 13/858,767, mailed on May 30, 2014, 12 pages. |
Non-Final Office Action; U.S. Appl. No. 13/386,638, mailed on Jun. 27, 2014, 12 pages. |
International Search Report; International Application No. PCT/US1155373, Applicant: Reshape Medical, Inc., dated: Jan. 20, 2012, 7 pages. |
International Search Report; International Application No. PCT/US2010/050260; Applicant: ReShape Medical, Inc., Mailing Date: Jun. 17, 2011, 9 pages. |
International Search Report; International Application No. PCT/US2011/031463; Applicant: ReShape Medical, Inc., Mailing Date: Jun. 27, 2011, 10 pages. |
Non-Final Office Action; U.S. Appl. No. 11/263,302; dated: Oct. 9, 2012, 6 pages. |
Non-Final Office Action; U.S. Appl. No. 11/694,536; dated: Oct. 26, 2011, 13 pages. |
Non-Final Office Action; U.S. Appl. No. 12/625,473; dated Jul. 12, 2012; 10 pages. |
Non-Final Office Action; U.S. Appl. No. 12/625,473; dated Oct. 24, 2011, 18 pages. |
Non-Final Office Action; U.S. Appl. No. 12/723,545; dated Feb. 29, 2012, 10 pages. |
Non-Final Office Action; U.S Appl. No. 12/753,751; dated Oct. 5, 2012, 8 pages. |
European Supplementary Search Report; EP Application No. 10802994.3, Applicant: ReShape Medical, Inc., mailed Jun. 28, 2013, 8 pgs. |
European Supplementary Search Report; EP Application No. 10802918.2, Applicant: ReShape Medical, Inc., mailed Jun. 5, 2013, 6 pgs. |
Extended European Search Report; Application No. EP11748141.6, Applicant: Reshape Medical, Inc., mailed Feb. 25, 2014, 6 pages. |
Extended European Search Report; Application EP11740536.5, Applicant: ReShape Medical, Inc., mailed Jul. 3, 2014, 8 pages. |
Extended European Search Report; Application EP11831683.5, Applicant: Reshape Medical, Inc., mailed Jul. 3, 2014, 8 pages. |
Final Office Action: U.S. Appl. No. 13/556,0-32, mailed on Jan. 28, 2014, 8 pages. |
Non-Final Office Action: U.S. Appl. No. 13/386,650, mailed on Jun. 3, 2014, 15 pages. |
Notice of Allowance; U.S. Appl. No. 12/753,803, dated May 13, 2014, 18 pages. |
Ostrovsky, ReShape Inflatable Gastric Balloon going on Trial as Weight Loss Option: http://www.medgadget.com/2010/reshape—inflatable—gastric—balloon—system—going—on—trial—as—wieight—loss—option.html Feb. 4, 2010, retrieved on Feb. 10, 2013. |
Final Office Action; U.S. Appl. No. 13/858,767, Mailing Date May 22, 2013, 12 pages. |
Extended European Search Report; Application No. EP11766679.2; Applicant: Reshape Medical, Inc., mailed Dec. 12, 2013, 6 pages. |
Cronin et al., “Normal small bowel wall characteristics on MR enterography,” European Journal of Radiology 74(2)207-211, Aug. 2010. |
Canadian 2nd Office Action Application No. 2680124, Applicant: ReShape Medical, Inc., mailed Jul. 9, 2015, 3 pages. |
European Examination Report; Application No. 06827313.5, Applicant: ReShape Medical Inc., mailed Jul. 13, 2015, 5 pages. |
European Examination Report; Application No. 06847847.8, Applicant: ReShape Medical Inc., mailed Jul. 13, 2015, 4 pages. |
Japanese Office Action; Application No. 2013-532976; Applicant: ReShape Medical, Inc., mailed Jun. 26, 2015, 10 pages. |
Canadian Office Action: Application No. CA 2680124, Applicant: Reshape Medical Corporation, mailed Nov. 4, 2014, 3 pages. |
Canadian Office Action; Application No. 2,691,530, mailed Dec. 18, 2014, 4 pages. |
Canadian Office Action; Application No. CA 2638163, Applicant: Reshape Medical Corporation, mailed Mar. 10, 2015, 4 pages. |
Canadian Office Action; Application No. CA 2638988, Applicant Reshape Medical Corporation, mailed Dec. 22, 2014 3 pages. |
Canadian Office Action; Application No. CA 2638988, Applicant Reshape Medical Corporation, mailed Mar. 6, 2014, 4 pages. |
Canadian Office Action; Application No. CA 2638989, Applicant: Reshape Medical Corporation, mailed May 22, 2013 3 pages. |
Canadian Office Action; Application No. CA 2640554, Applicant: Reshape Medical Corporation, mailed May 27, 2013, 2 pages. |
Canadian Office Action; Application No. CA2484838, Applicant: Reshape Medical, Inc., mailed Nov. 13, 2009, 3 pages. |
Canadian Office Action; Application No. CA2484838, Applicant: Reshape Medical, Inc., mailed Sep. 24, 2010, 3 pages. |
Canadian Office Action; Application No. CA2638163, Applicant: Reshape Medical Corporation, mailed Jul. 17, 2013, 2 pages. |
Canadian Office Action; Application No. CA2638988, Applicant: Reshape Medical Corporation, mailed May 28, 2013, 3 pages. |
Canadian Office Action; Application No. CA2780085, Applicant: Reshape Medical, Inc., mailed Jul. 23, 2012, 2 pages. |
European Examination Report; Application No. 03726447.0, Applicant: Applied Medical Resources Corporation: Oct. 26, 2007, 4 pages. |
European Examination Report; Application No. EP108002918.2, Applicant: Reshape Medical Inc., mailed Dec. 17, 2014, 5 pages. |
European Examination Report; Application No. EP108029943, Applicant: Reshape Medical Inc., mailed Dec. 18, 2014, 4 pages. |
European Examination Reported; Application No. 08771842.5, May 7, 2015, 5 pages. |
European Supplementary Search Report; Application No. 08771842.5, Apr. 24, 2015, 3 pages. |
Extended European Search Report; Application No. 08732989.2, Applicant: Reshape Medical, Inc., mailed Oct. 16, 2014, 7 pages. |
Japanese Final Office Action; Application No. JP2013-043712, mailed Nov. 15, 2013, 5 pages. |
Japanese Office Action; Application No. 2013-142327, mailed May 29, 2014, 4 pages. |
Japanese Office Action; Application No. 2014-52972; mailed Feb. 25, 2015, 7 pages. |
Japanese Office Action; Application No. JP2010-501261, mailed Sep. 7, 2012, 10 pages. |
Japanese Office Action; Application No. JP2010-515040, mailed Jan. 7, 2013, 18 pages. |
Japanese Office Action; Application No. JP2012-503759, mailed Mar. 24, 2014, 5 pages. |
Japanese Office Action; Application No. JP2013-43712, mailed Jan. 8, 2015, 8 pages. |
Japanese Office Action; Application. No. JP2013-043712, mailed Apr. 22, 2013, 5 pages. |
Gray, Henry. Anatomy of the Human Body. Philadelphia: Lea & Febiger, 1918. Section XI Splanchnology, 2g. The Small Intestine. Bartleby.com, 2000. Web. URL: www.bartleby.com/107/248.html. Accessed: Oct. 26, 2015. 12 pages. |
Partial Supplementary European Search Report for European Application No. 11740535.7, Applicant: ReShape Medical, Inc., mailed Oct. 20, 2015, 7 pages. |
Final Office Action for Japanese Application No. 2014-52972, Applicant: ReShape Medical, Inc., mailed on Oct. 9, 2015, 8 pages. |
Number | Date | Country | |
---|---|---|---|
20110178544 A1 | Jul 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11768152 | Jun 2007 | US |
Child | 13074956 | US |